Megadalton joins Waters' Immerse Cambridge labs

By The Science Advisory Board staff writers

November 19, 2020 -- Megadalton Solutions has expanded its collaboration with Waters to bring its charge detection mass spectrometry (CDMS) technology to a broader set of biopharma customers by joining Waters' Immerse Cambridge lab.

Megadalton's CDMS detector provides a high-throughput analytical tool for the cell and gene therapy sectors. The large molecule mass spectrometry technology is an important tool for the characterization and support of next-generation pharmaceutical biologics.

Through the agreement, Waters will conduct testing of Megadalton's CDMS technology within its Immerse Cambridge Innovation and Research Labs, using its collaborative engagements with academic and commercial pharma and biopharma partners.

Waters introduces new line of chromatography columns
Waters has launched Acquity Premier columns, a family of premium sub-2-μm columns that feature the company's MaxPeak high-performance surface technology.
Waters establishes innovation and research lab in Cambridge
Waters has established Immerse Cambridge, a new research laboratory in the heart of Cambridge, MA, where the company can partner with academic, research,...

Copyright © 2020

Interphex 2021
October 19-21
New York City, New York United States
Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter